Angelika Hanschmann Selected Research

Analgesics (Analgesic Drugs)

1/2008

Antihyperalgesic and analgesic properties of the N-methyl-D-aspartate (NMDA) receptor antagonist neramexane in a human surrogate model of neurogenic hyperalgesia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Angelika Hanschmann Research Topics

Disease

7	Stroke (Strokes) 01/2021 - 09/2014
4	Blepharospasm 10/2021 - 07/2011
3	Torticollis (Wryneck) 11/2014 - 09/2011
2	Cerebral Palsy (Spastic Diplegia) 01/2022 - 01/2021
2	Pain (Aches) 12/2013 - 01/2008
1	Muscle Spasticity (Spastic) 01/2021
1	Muscle Hypertonia 07/2020
1	Neck Pain (Cervicalgia) 09/2011
1	Deglutition Disorders (Dysphagia) 09/2011
1	Muscle Weakness 09/2011
1	Hyperalgesia 01/2008
1	Neuralgia (Stump Neuralgia) 01/2008
1	Postoperative Pain 01/2008

Drug/Important Bio-Agent (IBA)

15	incobotulinumtoxinA FDA Link 01/2022 - 07/2011
4	Pharmaceutical PreparationsIBA 10/2021 - 01/2008
3	Botulinum Toxins (Botulinum Toxin)IBA 10/2021 - 09/2014
3	Proteins (Proteins, Gene)FDA Link 10/2021 - 09/2011
3	Type A Botulinum Toxins (Botox)FDA Link 09/2014 - 09/2011
1	Neutralizing AntibodiesIBA 11/2014
1	abobotulinumtoxinA FDA Link 09/2014
1	Analgesics (Analgesic Drugs)IBA 01/2008
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2008
1	N-Methylaspartate (NMDA)IBA 01/2008
1	neramexaneIBA 01/2008
1	flupirtineIBA 01/2008
1	Capsaicin (Zostrix)FDA Link 01/2008

Therapy/Procedure

5	Injections 01/2021 - 09/2013
2	Therapeutics 07/2020 - 09/2014
1	Analgesia 01/2008